Latest filing published 31 Aug 2026 for Quest Diagnostics INC, €2.2M. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Michael e. Prevoznik (senior executive) discloses dealings in Quest Diagnostics Inc to SEC (Form 4). Over a trading history stretching from 5 May 2021 to 28 August 2026, the count stands at 30 filings.
Every open-market trade on record is a sale: 6 sales worth €5.7M. Besides market trades, the filings include 16 share grants and 7 option exercises. Since January 2026: no purchases and 3 sales on the market.
The newest entry dates from 31 August 2026: an option exercise of €2.2M, in Quest Diagnostics Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 30 declarations